Twogee Biotech raises $2.3M Seed (Germany, Aug 2026)
Reach the investors backing rounds like this
Backed by High-Tech Gründerfonds, Bayern Kapital +2 more · verified emails and LinkedIn on Datapile
Cardiometabolic Biotech Secures €6 Million Seed Round - N24 Haber
Twogee Biotech is a Munich-based biotechnology startup that specializes in tailor-made enzyme solutions for the industrial conversion of biomass into sustainable raw materials. The company focuses on transforming low-value biomass residues into high-value second-generation raw materials, enabling circular economy principles in the chemical industry.
Cardiometabolic Biotech Secures €6 Million Seed Round N24 Haber
| Nov 04, 2026 | Conlio | $6.9M | — | Germany |
| Nov 04, 2026 | Return | $903.0M | Debt | Germany |
| Nov 03, 2026 | Quint | $9.9M | — | Germany |
| Nov 03, 2026 | Quint Computing | $9.1M | — | Germany |
15,819 investors back startups in Germany
You just read who funded Twogee Biotech. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.